Novartis gets FDA approval for Cosentyx to treat active non-radiographic axial...

cafead

Administrator
Staff member
  • cafead   Jun 18, 2020 at 10:33: AM
via Novartis has secured approval from the US Food and Drug Administration (FDA) for its Cosentyx (secukinumab) to treat active non-radiographic axial spondyloarthritis (nr-axSpA).

article source
 

<